318
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Evaluation of a new point-of-care testing for creatinine and urea measurement

, , , , , , , , , & show all
Pages 290-297 | Received 19 Nov 2020, Accepted 21 Feb 2021, Published online: 28 Apr 2021

References

  • Oredsson S, Jonsson H, Rognes J, et al. A systematic review of triage-related interventions to improve patient flow in emergency departments. Scand J Trauma Resusc Emerg Med. 2011;19:43.
  • Jarvis PRE. Improving emergency department patient flow. Clin Exp Emerg Med. 2016;3(2):63–68.
  • Bargnoux A-S, Beaufils O, Oguike M, et al. Point-of-care creatinine testing in patients receiving contrast-enhanced computed tomography scan. Clin Chim Acta. 2018;478:111–113.
  • Stojkovic V, Delanaye P, Collard G, et al. Estimated glomerular filtration rate using a point of care measure of creatinine in patients with iohexol determinate GFR. Clin Chim Acta. 2019;499:123–127.
  • Snaith B, Harris MA, Shinkins B, et al. Point-of-care creatinine testing for kidney function measurement prior to contrast-enhanced diagnostic imaging: evaluation of the performance of three systems for clinical utility. Clin Chem Lab Med. 2018;56(8):1269–1276.
  • McIntosh BW, Vasek J, Taylor M, et al. Accuracy of bedside point of care testing in critical emergency department patients. Am J Emerg Med. 2018;36(4):567–570.
  • Love SA, Schulz K, Stack P, et al. Clinical evaluation of a new point-of-care system for chemistry panel testing. J Appl Lab Med. 2019;4(2):180–192.
  • Goyder C, Tan PS, Verbakel J, et al. Impact of point-of-care panel tests in ambulatory care: a systematic review and meta-analysis. BMJ Open. 2020;10(2):e032132.
  • Harris MA, Snaith B, Clarke R. Strategies for assessing renal function prior to outpatient contrast-enhanced CT: a UK survey. Br J Radiol. 2016;89(1067):20160077.
  • Schnabl KL, Bagherpoor S, Diker P, et al. Evaluation of the analytical performance of the Nova StatSensor creatinine meter and reagent strip technology for whole blood testing. Clin Biochem. 2010;43(12):1026–1029.
  • D'Orazio P, Conant J, Cervera J. Measurement of creatinine in whole blood samples supplemented to achieve increased creatinine concentrations. Clin Chem. 2008;54(2):451–452.
  • Erickson KA, Wilding P. Evaluation of a novel point-of-care system, the i-STAT portable clinical analyzer. Clin Chem. 1993;39(2):283–287.
  • Shephard MD. Point-of-care testing and creatinine measurement. Clin Biochem Rev. 2011;32(2):109–114.
  • Skurup A, Kristensen T, Wennecke G, et al. New creatinine sensor for point-of-care testing of creatinine meets the National Kidney Disease Education Program guidelines. Clin Chem Lab Med. 2008;46:3–8.
  • User verification of precision and estimation of bias; approved guideline-third edition. CLSI document EP15-A3. Wayne (PA): Clinical and Laboratory Standards Institute; 2014.
  • Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline. CLSI document EP06-A. Wayne (PA): Clinical and Laboratory Standards Institute; 2003.
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
  • Daugirdas JT. Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn. Adv Ren Replace Ther. 1995;2(4):295–304.
  • Terrier N, Jaussent I, Dupuy AM, et al. Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients. Nephrol Dial Transplant. 2008;23(1):345–353.
  • Interference testing in clinical chemistry; approved guideline – second edition. CLSI document EP07-A2. Wayne (PA): Clinical and Laboratory Standards Institute; 2005.
  • Dupuy AM, Bargnoux AS, Kuster N, et al. Determination of hemolysis cut-offs for biochemical and immunochemical analytes according to their value. Clin Chem Lab Med. 2020;58(8):1232–1241.
  • ISO Standard 5725, accuracy (trueness and precision) of measurement methods and results. Geneva, Switzerland: International Organization for Standardization; 1994.
  • Lippi G, Cadamuro J, von Meyer A, et al. Practical recommendations for managing hemolyzed samples in clinical chemistry testing. Clin Chem Lab Med. 2018;56(5):718–727.
  • Aarsand AK, Fernandez-Calle P, Webster C, et al. The EFLM biological variation database; 2019. [Internet]. Available from: https://biologicalvariation.eu/
  • Sandberg S, Fraser CG, Horvath AR, et al. Defining analytical performance specifications: consensus statement from the 1st strategic conference of the European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med. 2015;53(6):833–835.
  • Fraser CG. General strategies to set quality specifications for reliability performance characteristics. Scand J Clin Lab Invest. 1999;59(7):487–490.
  • Piéroni L, Delanaye P, Boutten A, et al. A multicentric evaluation of IDMS-traceable creatinine enzymatic assays. Clin Chim Acta. 2011;412(23–24):2070–2075.
  • Bargnoux AS, Kuster N, Cavalier E, et al. Serum creatinine: advantages and pitfalls. J Lab Precis Med. 2018;3:71.
  • Salvagno GL, Pucci M, Demonte D, et al. Analytical evaluation of radiometer ABL90 FLEX PLUS enzymatic creatinine assay. J Lab Precis Med. 2019;4:26.
  • van der Heijden C, Roosens L, Cluckers H, et al. Analytical and clinical performance of three hand-held point-of-care creatinine analyzers for renal function measurements prior to contrast-enhanced imaging. Clin Chim Acta. 2019;497:13–19.
  • Nataatmadja M, Fung AWS, Jacobson B, et al. Performance of StatSensor point-of-care device for measuring creatinine in patients with chronic kidney disease and postkidney transplantation. Can J Kidney Health Dis. 2020;7:2054358120970716.
  • Papadea C, Foster J, Grant S, et al. Evaluation of the i-STAT portable clinical analyzer for point-of-care blood testing in the intensive care units of a university children's hospital. Ann Clin Lab Sci. 2002;32:231–243.
  • Bahar B, DeChristopher PJ, Holmes EW, et al. Investigation of falsely decreased creatinine results observed from the Abbott I-STAT point-of-care device in use for testing specimens from ambulatory oncology patients. Point Care. 2016;15(2):72–77.
  • Couchoud C, Jager KJ, Tomson C, et al. Assessment of urea removal in haemodialysis and the impact of the European Best Practice Guidelines. Nephrol Dial Transplant. 2009;24(4):1267–1274.
  • Huang CY, Lee SY, Yang CW, et al. A simpler creatinine index can predict long-term survival in Chinese hemodialysis patients. PLoS One. 2016;11(10):e0165164.
  • Canaud B, Granger Vallée A, Molinari N, et al. Creatinine index as a surrogate of lean body mass derived from urea Kt/V, pre-dialysis serum levels and anthropometric characteristics of haemodialysis patients. PLoS One. 2014;9(3):e93286.
  • Larcher R, Kuster N, Bargnoux AS, et al. Discrepant post-filter ionized calcium concentrations by 2 common gas analyzers in continuous renal replacement therapy using regional citrate anticoagulation: another piece of the puzzle. Kidney Int. 2021;99(1):268–269.
  • Lippi G, Fontana R, Avanzini P, et al. Influence of spurious hemolysis on blood gas analysis. Clin Chem Lab Med. 2013;51:1651–1654.
  • Lippi G, Salvagno GL, Montagnana M, et al. Influence of hemolysis on routine clinical chemistry testing. Clin Chem Lab Med. 2006;44:311–316.
  • Nicolay A, Lorec AM, Gomez G, et al. Icteric human samples: icterus index and method of estimating an interference-free value for 16 biochemical analyses. J Clin Lab Anal. 2018;32(2):e22229.
  • Owen LJ, Keevil BG. Does bilirubin cause interference in Roche creatinine methods? Clin Chem. 2007;53(2):370–371.
  • Cobbaert CM, Baadenhuijsen H, Weykamp CW. Prime time for enzymatic creatinine methods in pediatrics. Clin Chem. 2009;55(3):549–558.
  • Greenberg N, Roberts WL, Bachmann LM, et al. Specificity characteristics of 7 commercial creatinine measurement procedures by enzymatic and Jaffe method principles. Clin Chem. 2012;58(2):391–401.
  • Roelofsen-de Beer RJAC, van Zelst BD, Vroling AB, et al. When results matter: reliable creatinine concentrations in hyperbilirubinemia patients. Clin Chem Lab Med. 2019;57(5):659–667.
  • Baird G. Preanalytical considerations in blood gas analysis. Biochem Med (Zagreb). 2013;23(1):19–27.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.